Menu

Studies

uMed are helping GP practices and their patients to participate in essential research. Below is a list of the ongoing observational and interventional studies that uMed are currently supporting. You can find more information about each as well as how to be involved within within each study page.

ACCESS-PD
Parkinsons predict-pd umed case study

Key Study Information:

  • Treatment Area:

    Parkinson's Disease

  • Study Aim:

    To advance our understanding of Parkinson’s Disease and accelerate the development of advanced therapies to improve outcomes for patients.

  • Sponsor/Owner:

    Queen Mary University of London

  • Goal:

    Ongoing patient recruitment of patient's diagnosed with Parkinson's Disease.

See Study Details Right Arrow

ADAMS
ADAMS

Key Study Information:

  • Treatment Area:

    Multiple Sclerosis

  • Study Aim:

    To discover whether the genes that contribute to MS risk are the same or different for people of non-European ancestry, with a focus on people from African & South Asian backgrounds.

  • Sponsor/Owner:

    Queen Mary University of London

  • Goal:

    400 patients

See Study Details Right Arrow

ALOPECIA

Key Study Information:

  • Treatment Area:

    Alopecia Areata

  • Study Aim:

    To assess the safety, efficacy & dose response characterisation of STSO1 (Dithranol/ProSilic) administered topically, once daily, to affected scalp areas for 6 months, in patients who have mild to moderate Alopecia Areata.

  • Sponsor/Owner:

    Soterios

  • Goal:

    100 patients with mild to moderate Alopecia

See Study Details Right Arrow

ITCHINESS

Key Study Information:

  • Treatment Area:

    Chronic Kidney Disease and Pruritus

  • Study Aim:

    To evaluate the efficacy and safety of MC2-25 Cream and MC2-25 vehicle in subjects with chronic kidney disease-associated pruritus (CKD aP).

  • Sponsor/Owner:

    MC2 Therapeutics

  • Goal:

    22 Patients: Non-Dialysis CKD stage 3.

    22 Patients: Non-dialysis CKD stage 4/5.

    Total: 44 Patients

See Study Details Right Arrow

APATURA

Key Study Information:

  • Treatment Area:

    Asthma

  • Study Aim:

    To understand the safety and efficacy of the drug AZD1402 in adults with moderate asthma, who regularly use inhaled corticosteroids (ICS) and long-acting beta-agonists (LABAs).

  • Sponsor/Owner:

    AstraZeneca

  • Goal:

    20 patients

See Study Details Right Arrow

TITANIA

Key Study Information:

  • Treatment Area:

    COPD

  • Study Aim:

    A study to discover whether a new investigational medication (Tozorakimab) could help reduce the number of exacerbations for people with COPD.

  • Sponsor/Owner:

    AstraZeneca

  • Goal:

    30+ patients with symptomatic COPD

See Study Details Right Arrow

HARMONIE

Key Study Information:

  • Treatment Area:

    RSV

  • Study Aim:

    To understand how strongly babies can be protected from serious illness due to RSV infection (respiratory syncytial virus) by giving them a single antibody dose.

  • Sponsor/Owner:

    LabCorp/SANOFI

  • Goal:

    Aims to recruit 12,000 babies <1 year old

See Study Details Right Arrow